GENERAL - THERAPIES
Total Payments
$33.6M
Transactions
16,856
Doctors
7,155
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $3.2M | 593 | 317 |
| 2021 | $717,897 | 1,068 | 680 |
| 2020 | $11.2M | 6,226 | 3,133 |
| 2019 | $608,011 | 531 | 378 |
| 2018 | $1.1M | 303 | 186 |
| 2017 | $16.7M | 8,135 | 3,827 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $11.0M | 71 | 32.8% |
| Current or prospective ownership or investment interest | $9.3M | 67 | 27.8% |
| Unspecified | $3.6M | 293 | 10.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.1M | 734 | 6.4% |
| Consulting Fee | $2.1M | 857 | 6.3% |
| Acquisitions | $1.9M | 25 | 5.6% |
| Grant | $1.4M | 224 | 4.3% |
| Travel and Lodging | $848,571 | 2,698 | 2.5% |
| Food and Beverage | $612,351 | 11,636 | 1.8% |
| Space rental or facility fees (teaching hospital only) | $563,293 | 21 | 1.7% |
| Charitable Contribution | $68,300 | 18 | 0.2% |
| Education | $30,236 | 212 | 0.1% |
Payments by Type
General
$30.0M
16,563 transactions
Research
$3.6M
293 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| INTERRUPT AF | BOSTON SCIENTIFIC CORPORATION | $647,469 | 0 |
| Clinical Data and Value Proposition for Eluvia Ranger Rotablator and IVUS Using the Vascular Outcomes Collaborative | BOSTON SCIENTIFIC CORPORATION | $317,500 | 1 |
| The SYNERGY sub-study for TWILIGHT Trial | Boston Scientific Corporation | $200,000 | 0 |
| CREST 2 REGISTRY | BOSTON SCIENTIFIC CORPORATION | $150,000 | 0 |
| SAFE PAD | BOSTON SCIENTIFIC CORPORATION | $148,131 | 0 |
| Cerebral Protection of Acute Embolic Burden During Transcatheter Aortic Valve Implantation in Low Risk Patients | BOSTON SCIENTIFIC CORPORATION | $147,650 | 0 |
| XLPAD Study | BOSTON SCIENTIFIC CORPORATION | $140,000 | 0 |
| C2R | Boston Scientific Corporation | $125,000 | 0 |
| Synergy Stent in Left Main PCI - OCT Strut Coverage Study | Boston Scientific Corporation | $123,980 | 0 |
| RESCUE VT | Boston Scientific Corporation | $92,000 | 0 |
| XLPAD Study | Boston Scientific Corporation | $87,750 | 0 |
| Ventricular Tachycardia Ablation in Patients with Coronary Disease Functionalguided Substrate Ablation | Boston Scientific Corporation | $86,000 | 0 |
| H-FIB | Boston Scientific Corporation | $80,000 | 0 |
| HUCS | BOSTON SCIENTIFIC CORPORATION | $70,277 | 0 |
| Electrogram analysis for AFib substrate characterization | BOSTON SCIENTIFIC CORPORATION | $66,950 | 0 |
| MANAGE TAVR Database MANAGEment of Transcatheter Aortic Valve Therapy | BOSTON SCIENTIFIC CORPORATION | $60,000 | 0 |
| PROGRESS CTO Registry MENATA | BOSTON SCIENTIFIC CORPORATION | $58,750 | 0 |
| Ischemic Stroke with Sentinel Device during Transcatheter Aortic Valve Replacement | BOSTON SCIENTIFIC CORPORATION | $56,250 | 0 |
| Smartphone based coronary artery disease management | BOSTON SCIENTIFIC CORPORATION | $55,353 | 0 |
| CRT in Chemotherapy-induced Cardiomyopathy | Boston Scientific Corporation | $55,000 | 0 |
Top Doctors Receiving Payments for GENERAL - THERAPIES
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Brooklyn, NY | $6.5M | 567 |
| , MD | Obstetrics & Gynecology | Milwaukee, WI | $5.8M | 1 |
| , MD | Surgery | Ann Arbor, MI | $4.1M | 4 |
| , M.D | Urogynecology and Reconstructive Pelvic Surgery | Skokie, IL | $3.9M | 4 |
| , M.D | Urology | Baltimore, MD | $1.3M | 1 |
| , M.D | Clinical Cardiac Electrophysiology | New York, NY | $800,420 | 7 |
| , M.D | Radiation Oncology | Grand Forks, ND | $797,706 | 1 |
| Leo Hopkins | — | Buffalo, NY | $782,651 | 3 |
| , MD | Neurological Surgery | Los Angeles, CA | $604,420 | 1 |
| , M.D | Internal Medicine | San Francisco, CA | $331,711 | 2 |
| , MD | Cardiovascular Disease | Austin, TX | $321,099 | 4 |
| , M.D | Cardiovascular Disease | Sacramento, CA | $318,329 | 7 |
| , MD | Specialist | Amarillo, TX | $239,330 | 3 |
| , MD | Diagnostic Radiology | Charleston, SC | $211,482 | 2 |
| , M.D., PH.D., MBA | Surgery | South Barrington, IL | $175,000 | 2 |
| , M.D | Family Medicine | West Allis, WI | $158,421 | 1 |
| , O.D | Optometrist | Frederick, MD | $155,518 | 2 |
| Frank Phillips | — | Chicago, IL | $139,107 | 3 |
| , MD | Anesthesiology | Issaquah, WA | $139,107 | 3 |
| , MD | Diagnostic Radiology | Minneapolis, MN | $138,873 | 3 |
| , MD | Pain Medicine | Charleston, WV | $137,625 | 2 |
| , MD | Diagnostic Radiology | Boston, MA | $127,628 | 11 |
| , M.D | Vascular & Interventional Radiology | Charlottesville, VA | $111,043 | 2 |
| , M.D | Reproductive Endocrinology | Houston, TX | $91,320 | 1 |
| , MD, PHD | Neurological Surgery | Buffalo, NY | $70,493 | 2 |
Ad
Manufacturing Companies
- BOSTON SCIENTIFIC CORPORATION $22.2M
- Boston Scientific Corporation $11.4M
Product Information
- Type Device
- Total Payments $33.6M
- Total Doctors 7,155
- Transactions 16,856
About GENERAL - THERAPIES
GENERAL - THERAPIES is a device associated with $33.6M in payments to 7,155 healthcare providers, recorded across 16,856 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2017 to 2022. In 2022, $3.2M was paid across 593 transactions to 317 doctors.
The most common payment nature for GENERAL - THERAPIES is "Royalty or License" ($11.0M, 32.8% of total).
GENERAL - THERAPIES is associated with 20 research studies, including "INTERRUPT AF" ($647,469).